174 related articles for article (PubMed ID: 1921786)
1. Entry of human immunodeficiency virus infection into a population of injecting drug users, Victoria, 1990.
Crofts N; Hay M
Med J Aust; 1991 Sep; 155(6):378-82. PubMed ID: 1921786
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
4. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
[TBL] [Abstract][Full Text] [Related]
5. HIV infection among injecting drug users in north-east Malaysia, 1992.
Singh S; Crofts N
AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462
[TBL] [Abstract][Full Text] [Related]
6. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of HIV-1 infection in Victoria. The Victorian Collaborative Group on HIV and AIDS Surveillance (VCGHAS).
Gertig D; Crofts N; Stevenson E; Breschkin A
Med J Aust; 1993 Jan; 158(1):17-20. PubMed ID: 8417284
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection among a cohort of Victorian injecting drug users.
Crofts N; Hopper JL; Bowden DS; Breschkin AM; Milner R; Locarnini SA
Med J Aust; 1993 Aug; 159(4):237-41. PubMed ID: 7692222
[TBL] [Abstract][Full Text] [Related]
9. Determinants of HIV risk among men who have homosexual sex and inject drugs.
Crofts N; Marcus L; Meade J; Sattler G; Wallace J; Sharp R
AIDS Care; 1995; 7(5):647-55. PubMed ID: 8652699
[TBL] [Abstract][Full Text] [Related]
10. HIV in injecting drug users in Edinburgh: prevalence and correlates.
Davies AG; Dominy NJ; Peters A; Bath GE; Burns SM; Richardson AM
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):399-405. PubMed ID: 7882106
[TBL] [Abstract][Full Text] [Related]
11. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
[TBL] [Abstract][Full Text] [Related]
13. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
[TBL] [Abstract][Full Text] [Related]
14. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M; Mella I; Moi H; Eskild A
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
[TBL] [Abstract][Full Text] [Related]
15. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
16. HIV risk behaviour among injecting drug users in Perth: the Australian National AIDS and Injecting Drug Use Study.
Loxley WM; Marsh AM; Hawks DV; Quigley AJ
Med J Aust; 1992 May; 156(10):687-92. PubMed ID: 1620015
[TBL] [Abstract][Full Text] [Related]
17. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand.
Kitayaporn D; Vanichseni S; Mastro TD; Raktham S; Vaniyapongs T; Des Jarlais DC; Wasi C; Young NL; Sujarita S; Heyward WL; Esparza J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):289-95. PubMed ID: 9803972
[TBL] [Abstract][Full Text] [Related]
18. Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.
Uusküla A; McMahon JM; Kals M; Talu A; Abel-Ollo K; Rüütel K; Des Jarlais DC
AIDS Behav; 2013 Mar; 17(3):879-88. PubMed ID: 22038080
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India.
Panda S; Kumar MS; Lokabiraman S; Jayashree K; Satagopan MC; Solomon S; Rao UA; Rangaiyan G; Flessenkaemper S; Grosskurth H; Gupte MD
J Acquir Immune Defic Syndr; 2005 May; 39(1):9-15. PubMed ID: 15851908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
